Bionano Genomics (BNGO) Operating Income (2017 - 2025)
Historic Operating Income for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to -$8.5 million.
- Bionano Genomics' Operating Income rose 8055.17% to -$8.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$36.7 million, marking a year-over-year increase of 6859.35%. This contributed to the annual value of -$104.0 million for FY2024, which is 5169.09% up from last year.
- As of Q3 2025, Bionano Genomics' Operating Income stood at -$8.5 million, which was up 8055.17% from -$7.8 million recorded in Q2 2025.
- Over the past 5 years, Bionano Genomics' Operating Income peaked at -$7.8 million during Q2 2025, and registered a low of -$113.2 million during Q3 2023.
- Moreover, its 5-year median value for Operating Income was -$28.8 million (2021), whereas its average is -$29.1 million.
- Its Operating Income has fluctuated over the past 5 years, first crashed by 25214.78% in 2023, then skyrocketed by 8055.17% in 2025.
- Bionano Genomics' Operating Income (Quarter) stood at -$28.8 million in 2021, then tumbled by 30.38% to -$37.5 million in 2022, then skyrocketed by 33.51% to -$25.0 million in 2023, then surged by 52.15% to -$11.9 million in 2024, then rose by 28.5% to -$8.5 million in 2025.
- Its Operating Income stands at -$8.5 million for Q3 2025, versus -$7.8 million for Q2 2025 and -$8.5 million for Q1 2025.